Jeffrey Moore, President

Jeff Moore joined MPH in 2008. Previously, Dr. Moore was a Kauffman Fellow with the early stage healthcare venture capital firm Research Corporation Technologies (RCT). He has held various business and scientific roles at Millennium Pharmaceuticals and Scriptgen. He received his DPhil from Oxford and postdoctoral training at Harvard Medical School, studying biochemistry, infectious disease and immunology. He received his MBA as a Sloan Fellow at MIT.

Naoya Sato, Director

Naoya Sato joined MPH in March 2015. Dr. Sato worked in the Research Department of Mitsubishi Tanabe Pharma Corporation (MTPC). His previous role at MTPC was management of early stage drug discovery research in autoimmune, kidney, metabolism, psychiatric and neurodegenerative diseases, as well as new technology platforms including human iPS cells for drug discovery. He received his Ph.D. from Osaka University, studying molecular biology, neural development and Alzheimer's disease.

Laura Tadvalkar, Senior Associate

Laura Tadvalkar joined MPH in 2017. Prior to MPH, Dr. Tadvalkar was a Manager at Clarion Healthcare, a boutique life sciences consulting firm in Boston. At Clarion, she worked with global biopharmaceutical companies and emerging biotechs on commercial strategy for therapeutics & drug/device combinations in rare disease and oncology. She received a BS in Chemistry from Yale University and a PhD in Chemical Biology from Harvard University, studying mitochondrial physiology, disease, and role in cancer metabolism.